MBX Biosciences Inc (MBX) PT Raised to $88 at Truist Securities
Tweet
Share
E-mailGet Alerts MBX Hot Sheet
Price: $64.21 -3.28%
Rating Summary:
11 Buy, 0 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
11 Buy, 0 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Truist Securities analyst Srikripa Devarakonda raised the price target on MBX Biosciences Inc (NASDAQ: MBX) to $88.00 (from $70.00) while maintaining a Buy rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $325 at Oppenheimer
- Minimax Group Inc (100:HK) PT Raised to HK$804 at Macquarie
- MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
